Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [IR] Samsung Electronics (005930) – Q2 2024 Earnings Presentation / 2024-07-31 IR Room
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2024 Earnings Presentation / 2024-07-31 IR Room
  • [Research] LigaChem Biosciences (141080) – Mirae Asset Securities | Clinical Milestones · Commercialization Potential · Platform PoC / 2025-05-23 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q1 2025 Earnings Presentation / 2025-04-29 IR Room
  • [Research] SK hynix (000660 / SKHY) – Daishin | Capex Discipline · Multi-Year LTA · Shareholder Returns / 2026-01-30 Research
  • [Research] LigaChem Biosciences (141080) – Kyobo Securities | Pipeline Clinical Progress · IND Filings · Tech Transfer / 2026-04-01 Research
  • [Research] Samsung SDI (006400) – iM Securities | ESS Business Pivot · AMPC Benefits · Earnings Visibility / 2026-07-31 Research
  • [Research] LIG D&A (079550) – Shinhan Securities | 1Q26 Surprise · Demand Surge · Long-term Compounding / 2026-05-08 Research

[Research] SK hynix (000660 / SKHY) – Eugene Investment | HBM Demand · AI Accelerator Diversification · Profitability / 2026-01-21

Posted on January 21, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Eugene Investment & Securities

Analyst : Sojung Yim

Investment Rating : BUY (Maintained)

Target Price : 990,000 KRW (Raised)

Core Momentum : Diversification of AI computing architectures across GPUs, CPUs, and ASIC accelerators is expected to structurally expand high-end memory demand centered on HBM, supporting industry-leading profitability and a sustained valuation premium.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price: 990,000 KRW (Based on Target P/B 3.5x applied to 2026F BPS, Raised)
  • Investment Rating: BUY (Maintained)
  • 2026F Financial Outlook: Revenue 190.30 trillion KRW, Operating Profit 115.82 trillion KRW, Net Income 93.70 trillion KRW
  • EPS: 128,671 KRW (2026E)
  • Valuation Multiples: PER 5.8x, PBR 2.6x, EV/EBITDA 3.6x, ROE 58.0% (Based on 2026E)

🚀 2. [Market Opportunities & Business Outlook]

  • 4Q25 Preview: Revenue is expected to reach 34.5 trillion KRW (+75% YoY, +41% QoQ) and operating profit 20.1 trillion KRW (+148% YoY, +76% QoQ), beating consensus estimates by +12% and +24%, respectively. Annual operating margin, previously in the mid-40% range, is projected to exceed 60% by 2026, marking the strongest profitability among the top three memory players.
  • Product & Demand Outlook: While HBM revenue proportion may decline slightly QoQ due to sharp rebounds in legacy DRAM prices, HBM revenue share is projected to maintain the mid-to-high 30% range backed by steady demand for next-gen and custom HBM.
  • AI Ecosystem Expansion: As the expansion speed of CPU and ASIC-based accelerator ecosystems entering the AI server market accelerates, high-end memory demand based on diverse computing architectures beyond GPUs is expected to enter a structural growth phase over the mid-to-long term.
  • Valuation Perspective: Valuation upside driven by generic DRAM price increases—currently a key market momentum—is limited. However, a premium is justified given the expansion of high-end memory demand centered on HBM and the resulting profitability improvements.

📝 Editor’s Comment (Perspective)

The analyst views SK hynix as an enterprise delivering overwhelming profitability driven by expanded high-end memory demand centered on HBM, enjoying structural growth amid a diversifying AI ecosystem. The analyst highlights high-end differentiation and strong earnings power that go beyond generic price uptrends.

To verify this investment thesis, one should track whether 4Q25 earnings meet expectations (revenue of 34.5 trillion KRW, operating profit of 20.1 trillion KRW), if the HBM revenue share stably maintains the mid-to-high 30% range, and how CPU/ASIC accelerator ecosystem expansions translate into actual solid high-end memory demand. These indicators can be monitored through upcoming quarterly reports and regulatory filings via DART.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] SK hynix (000660 / SKHY) – Mirae Asset | DRAM Pricing · Big Tech Demand · Earnings Upgrades / 2026-01-19
Next Post: [Research] Alteogen (196170) – Shinhan Securities | GSK Deal Supports Low Patent Risk View · Keytruda SC Royalty Calibrated · Target Price Adjusted / 2026-01-21

Related Posts

  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Profit Turnaround / 2026-06-30 Research
  • [Research] Samsung Biologics (207940) – IBK Securities | Plant 5 PPQ Revenue · US Site Consolidation · Guidance Revision Potential / 2026-04-23 Research
  • [Research] LIG D&A (079550) – SK Securities | CapEx Expansion · Global Interceptor Shortage · Earnings Quality / 2026-08-10 Research
  • [Research] SK hynix (000660 / SKHY) – Daishin | Memory ASP · Earnings Upgrades · Valuation Appeal / 2026-03-16 Research
  • [Research] LIG D&A (079550) – DS Investment & Securities | Order Expansion · Iraq Cheongung-II Mass Production · Long-term Earnings Growth / 2026-08-07 Research
  • [Research] ABL Bio (298380) – Kiwoom Securities | ABL301 Deprioritization · ABL001 Valuation · Grabody B Validity / 2026-02-02 Research
  • [Research] SK hynix (000660 / SKHY) – Kyobo | AI Server Demand · Memory ASP · High-Value Product Mix / 2026-01-30 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | Supply Constraints · Memory Pricing · LTA / 2026-04-24 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | AI Infrastructure · LTA · HBM Demand / 2026-06-09 Research
  • [Research] Samsung SDI (006400) – Hanwha Investment & Securities | Delayed EV Recovery · ESS Highlights as Sole Driver · Target Price Cut / 2026-01-07 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q1 2026 Earnings Presentation / 2026-04-30 IR Room
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI Server Demand · Supply Deficit · FCBGA Technical Bottleneck / 2026-07-20 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | LTA · HBM Demand · Valuation Re-rating / 2026-05-27 Research
  • [Research] Samsung Biologics (207940) – iM Securities | Annual Operating Profit Surpasses KRW 2T · Pure-CDMO Transition · Three-Pillar Growth Strategy / 2026-01-22 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme